D-1825-2015 Class I Terminated

Recalled by Pharmedium Services, LLC — Lake Forest, IL

FDA drug recall D-1825-2015 was initiated by Pharmedium Services, LLC on Jan 28, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human… The recall status is terminated (terminated Jan 27, 2017). Affected quantity: 663 bags.

Recall Details

Product Type
Drugs
Report Date
Sep 30, 2015
Initiation Date
Jan 28, 2015
Termination Date
Jan 27, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
663 bags

Product Description

Fentanyl Citrate, 5 mcg per mL (1,250 mcg per 250 mL), 250 mL total volume in a 250 mL LifeCare bag in Sodium Chloride 0.9%, IV Use Only, Rx only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 36141, NDC# 61553-107-50

Reason for Recall

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Distribution Pattern

Nationwide

Code Information

Lot #: 14303122M, Exp 01/28/15; 14309029M, Exp 02/02/15; 14315067M, Exp 02/09/15; 14317040M, Exp 02/11/15; 14318026M, Exp 02/12/15; 14323089M, Exp 02/17/15; 14325128M, 14325124M, Exp 02/19/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1825-2015
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.